"Serum prostate-specific antigen for the early detection whore in this moment скачать of prostate cancer: always, never, or only sometimes?".
"Screening and prostate-cancer mortality in a randomized European study".
22 The Canadian Urological Association in 2017 suggests screening be offered as a possibility to those who are expected to live more than 10 years with the final decision based on shared decision making."Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit".Eating a diet high in fat or drinking alcoholic beverages.A b Bennett HY, Roberts MJ, Doi SA, Gardiner RA (June 2016).Though the death rates from prostate cancer continue to decline, 238,590 men were diagnosed with prostate cancer in 2013 while 29,720 died as a result.How common is prostate cancer?"Prostate-specific antigen testing across the spectrum of prostate cancer".And European large scale screening effectiveness trial results AUA (2008).Preventive Services Task Force.Harvey Turner available under the CC.0 license.Greene KL, Albertsen PC, Babaian RJ, Carter HB, Gann PH, Han M, Kuban DA, Sartor AO, Stanford JL, Zietman A, Carroll P (January 2013).Van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH, Schröder FH (January 2010).Retrieved "Prostate cancer screening: Should you get a PSA test?" m, updated March 6, 2010 Haythorn MR, Ablin RJ (August 2011).
"Systematic review of complications of prostate biopsy".ProtecT (July 25, 2007).35 In those over the age of 70 PSA based screening is still recommended against.AUA statement March 2009 following publication.S.17 The final recommendation for that age group states screening should only be done in those who wish.51 The "Comparison Arm" has yet to report as of early 2018.These factors are different for every man and, therefore, the benefits of screening should be considered in the broader perspective." 38 39 As of 2018, the UK National Health Service did not offer general PSA screening, for similar reasons to those given above."ProtecT Study (Prostate testing for cancer and Treatment.28 It is likely to become the standard imaging modality in the staging of intermediate-to-high risk primary prostate cancer.
A b c Bell, N; Connor Gorber, S; Shane, A; Joffres, M; Singh, H; Dickinson, J; Shaw, E; Dunfield, L; Tonelli, M; Canadian Task Force on Preventive Health, Care.